Table 2.
Genetic alteration | BRCA1 | BRCA2 |
---|---|---|
Pathogenic variants | 17 | 18 |
Frameshift | 10 | 8 |
Nonsense | 7 | 10 |
Unclassified variants | 33 | 47 |
1000 Genomes Phase 3 MAFs in EAS (< 0.02) | 26 | 40 |
MAF in 328 breast cancer patients (> 0.005) | 7 | 12 |
Genotyping in controls | 6 | 9 |
MAF, minor allele frequency; EAS, East-Asian population.